JP2010511672A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010511672A5 JP2010511672A5 JP2009539742A JP2009539742A JP2010511672A5 JP 2010511672 A5 JP2010511672 A5 JP 2010511672A5 JP 2009539742 A JP2009539742 A JP 2009539742A JP 2009539742 A JP2009539742 A JP 2009539742A JP 2010511672 A5 JP2010511672 A5 JP 2010511672A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- het
- group
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 49
- -1 cyano, formyl Chemical group 0.000 claims 46
- 150000001875 compounds Chemical class 0.000 claims 33
- 125000003118 aryl group Chemical group 0.000 claims 30
- 125000001475 halogen functional group Chemical group 0.000 claims 15
- 229910052739 hydrogen Inorganic materials 0.000 claims 15
- 239000001257 hydrogen Substances 0.000 claims 14
- 125000001424 substituent group Chemical group 0.000 claims 13
- 125000003545 alkoxy group Chemical group 0.000 claims 12
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 11
- 229910052757 nitrogen Inorganic materials 0.000 claims 11
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 11
- 125000003710 aryl alkyl group Chemical group 0.000 claims 10
- 125000003386 piperidinyl group Chemical group 0.000 claims 10
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 9
- 125000001188 haloalkyl group Chemical group 0.000 claims 8
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 8
- 125000004663 dialkyl amino group Chemical group 0.000 claims 7
- 125000004414 alkyl thio group Chemical group 0.000 claims 6
- 125000005984 hexahydro-1H-1,4-diazepinyl group Chemical group 0.000 claims 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 6
- 125000004076 pyridyl group Chemical group 0.000 claims 6
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 6
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- 208000035143 Bacterial infection Diseases 0.000 claims 5
- 125000002393 azetidinyl group Chemical group 0.000 claims 5
- 208000022362 bacterial infectious disease Diseases 0.000 claims 5
- 239000002585 base Substances 0.000 claims 5
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 5
- 125000005943 1,2,3,6-tetrahydropyridyl group Chemical group 0.000 claims 4
- 239000002253 acid Substances 0.000 claims 4
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 4
- 125000006350 alkyl thio alkyl group Chemical group 0.000 claims 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 4
- 239000002904 solvent Substances 0.000 claims 4
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 claims 3
- 150000001204 N-oxides Chemical class 0.000 claims 3
- 241000191967 Staphylococcus aureus Species 0.000 claims 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 3
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 150000002431 hydrogen Chemical class 0.000 claims 3
- 125000002757 morpholinyl group Chemical group 0.000 claims 3
- 125000001624 naphthyl group Chemical group 0.000 claims 3
- 125000004193 piperazinyl group Chemical group 0.000 claims 3
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 claims 3
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims 2
- 125000006619 (C1-C6) dialkylamino group Chemical group 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 2
- 125000004103 aminoalkyl group Chemical group 0.000 claims 2
- 239000003242 anti bacterial agent Substances 0.000 claims 2
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 2
- 239000003054 catalyst Substances 0.000 claims 2
- 125000004473 dialkylaminocarbonyl group Chemical group 0.000 claims 2
- 125000004438 haloalkoxy group Chemical group 0.000 claims 2
- 125000002883 imidazolyl group Chemical group 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 231100000252 nontoxic Toxicity 0.000 claims 2
- 230000003000 nontoxic effect Effects 0.000 claims 2
- 125000003373 pyrazinyl group Chemical group 0.000 claims 2
- 125000003226 pyrazolyl group Chemical group 0.000 claims 2
- 125000002098 pyridazinyl group Chemical group 0.000 claims 2
- 125000000168 pyrrolyl group Chemical group 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 1
- 241000192125 Firmicutes Species 0.000 claims 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 claims 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 claims 1
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims 1
- 241000193998 Streptococcus pneumoniae Species 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000003513 alkali Substances 0.000 claims 1
- 125000005094 alkyl carbonyl amino alkyl group Chemical group 0.000 claims 1
- 150000001412 amines Chemical group 0.000 claims 1
- 125000001769 aryl amino group Chemical group 0.000 claims 1
- 125000005418 aryl aryl group Chemical group 0.000 claims 1
- 125000005129 aryl carbonyl group Chemical group 0.000 claims 1
- 125000004104 aryloxy group Chemical group 0.000 claims 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims 1
- 125000004604 benzisothiazolyl group Chemical group S1N=C(C2=C1C=CC=C2)* 0.000 claims 1
- 125000005605 benzo group Chemical group 0.000 claims 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 125000002576 diazepinyl group Chemical group N1N=C(C=CC=C1)* 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000012458 free base Substances 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000002632 imidazolidinyl group Chemical group 0.000 claims 1
- 125000001041 indolyl group Chemical group 0.000 claims 1
- 125000001786 isothiazolyl group Chemical group 0.000 claims 1
- 125000000842 isoxazolyl group Chemical group 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 229960003085 meticillin Drugs 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 125000002950 monocyclic group Chemical group 0.000 claims 1
- 125000002911 monocyclic heterocycle group Chemical group 0.000 claims 1
- 125000002971 oxazolyl group Chemical group 0.000 claims 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 claims 1
- UCQFSGCWHRTMGG-UHFFFAOYSA-N pyrazole-1-carboximidamide Chemical compound NC(=N)N1C=CC=N1 UCQFSGCWHRTMGG-UHFFFAOYSA-N 0.000 claims 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 claims 1
- 125000001422 pyrrolinyl group Chemical group 0.000 claims 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- UXAWXZDXVOYLII-UHFFFAOYSA-N tert-butyl 2,5-diazabicyclo[2.2.1]heptane-2-carboxylate Chemical compound C1C2N(C(=O)OC(C)(C)C)CC1NC2 UXAWXZDXVOYLII-UHFFFAOYSA-N 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
- 230000009466 transformation Effects 0.000 claims 1
- 238000000844 transformation Methods 0.000 claims 1
- 125000004306 triazinyl group Chemical group 0.000 claims 1
- 125000001425 triazolyl group Chemical group 0.000 claims 1
- 0 *Cc1c(*)c2ccccc2nc1* Chemical compound *Cc1c(*)c2ccccc2nc1* 0.000 description 6
- BIWPGLUVRQJKPV-UHFFFAOYSA-N CNc1c(C(C(CCCCN2C(C3)CN(C)C3C2)(c2ccc(cccc3)c3c2)O)c2ccccc2)cc(cccc2)c2n1 Chemical compound CNc1c(C(C(CCCCN2C(C3)CN(C)C3C2)(c2ccc(cccc3)c3c2)O)c2ccccc2)cc(cccc2)c2n1 BIWPGLUVRQJKPV-UHFFFAOYSA-N 0.000 description 1
- PJHLPOYVJJRCRB-UHFFFAOYSA-N COc(c(C(C(CCCCN1CCNCCC1)(c1ccc(cccc2)c2c1)O)c1ccccc1)c1)nc(cc2)c1cc2Br Chemical compound COc(c(C(C(CCCCN1CCNCCC1)(c1ccc(cccc2)c2c1)O)c1ccccc1)c1)nc(cc2)c1cc2Br PJHLPOYVJJRCRB-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06125545 | 2006-12-06 | ||
| EP06125545.1 | 2006-12-06 | ||
| PCT/EP2007/063319 WO2008068272A2 (en) | 2006-12-06 | 2007-12-04 | Antibacterial quinoline derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010511672A JP2010511672A (ja) | 2010-04-15 |
| JP2010511672A5 true JP2010511672A5 (enExample) | 2010-11-11 |
| JP5466013B2 JP5466013B2 (ja) | 2014-04-09 |
Family
ID=38048032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009539742A Expired - Fee Related JP5466013B2 (ja) | 2006-12-06 | 2007-12-04 | 抗菌性キノリン誘導体 |
Country Status (33)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO2970B1 (en) * | 2006-12-06 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| CN104254527B (zh) * | 2012-04-27 | 2017-05-31 | 詹森药业有限公司 | 抗菌的喹啉衍生物 |
| US9617244B2 (en) | 2012-04-27 | 2017-04-11 | Janssen Pharmaceutica Nv | Antibacterial quinoline derivatives |
| CA3253487A1 (en) | 2022-03-14 | 2023-09-21 | Slap Pharmaceuticals Llc | MULTICYCLICAL COMPOUNDS |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965572A (en) * | 1996-10-28 | 1999-10-12 | The United States Of America As Respresented By The Secretary Of The Army | Methods for treating antibiotic-resistant infections |
| ATE463482T1 (de) * | 2002-07-25 | 2010-04-15 | Janssen Pharmaceutica Nv | Chinolinderivate und deren verwendung als mycobakterielle inhibitoren |
| PT1711181E (pt) * | 2004-01-23 | 2009-12-29 | Janssen Pharmaceutica Nv | Derivados quinolina e sua utilização como inibidores micobacterianos |
| CN1910154B (zh) * | 2004-01-29 | 2011-08-17 | 詹森药业有限公司 | 用作分枝杆菌抑制剂的喹啉衍生物 |
| AP2037A (en) * | 2004-05-28 | 2009-10-09 | Janssen Pharmaceutica Nv | Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases |
| EE05394B1 (et) * | 2004-12-24 | 2011-04-15 | Janssen Pharmaceutica N.V. | Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis |
| EE05697B1 (et) * | 2005-06-08 | 2014-02-17 | Janssen Pharmaceutica N.V. | Kinoliini derivaadid kui antibakteriaalsed toimeained |
| UA88701C2 (ru) * | 2005-06-28 | 2009-11-10 | Янссэн Фармацэвтика Н.В. | Производные хинолина как антибактериальные агенты |
| JO2752B1 (en) * | 2005-06-28 | 2014-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
| JO2837B1 (en) * | 2005-08-03 | 2014-09-15 | جانسن فارمسيتكا ان في | Quinoline derivatives acting as antibacterial agents |
| JO2855B1 (en) * | 2005-08-03 | 2015-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
| JO2952B1 (en) * | 2005-08-03 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
-
2007
- 2007-12-02 JO JO2007510A patent/JO2683B1/en active
- 2007-12-04 UA UAA200904443A patent/UA101307C2/ru unknown
- 2007-12-04 PL PL07847817T patent/PL2099761T3/pl unknown
- 2007-12-04 PT PT07847817T patent/PT2099761E/pt unknown
- 2007-12-04 CA CA2668558A patent/CA2668558C/en active Active
- 2007-12-04 JP JP2009539742A patent/JP5466013B2/ja not_active Expired - Fee Related
- 2007-12-04 DE DE602007010182T patent/DE602007010182D1/de active Active
- 2007-12-04 WO PCT/EP2007/063319 patent/WO2008068272A2/en not_active Ceased
- 2007-12-04 HR HR20110024T patent/HRP20110024T1/hr unknown
- 2007-12-04 AU AU2007328892A patent/AU2007328892B2/en not_active Ceased
- 2007-12-04 KR KR1020097013568A patent/KR101553600B1/ko not_active Expired - Fee Related
- 2007-12-04 MX MX2009005906A patent/MX2009005906A/es active IP Right Grant
- 2007-12-04 EP EP07847817A patent/EP2099761B1/en active Active
- 2007-12-04 CN CN200780045128.8A patent/CN101547906B/zh not_active Expired - Fee Related
- 2007-12-04 DK DK07847817.9T patent/DK2099761T3/da active
- 2007-12-04 NZ NZ576862A patent/NZ576862A/en not_active IP Right Cessation
- 2007-12-04 SI SI200730471T patent/SI2099761T1/sl unknown
- 2007-12-04 RS RS20110019A patent/RS51582B/sr unknown
- 2007-12-04 AT AT07847817T patent/ATE486061T1/de active
- 2007-12-04 ES ES07847817T patent/ES2354755T3/es active Active
- 2007-12-04 AP AP2009004873A patent/AP2477A/xx active
- 2007-12-04 US US12/516,420 patent/US20100063026A1/en not_active Abandoned
- 2007-12-04 MY MYPI20092287A patent/MY145940A/en unknown
- 2007-12-04 ME MEP-2011-10A patent/ME01230B/me unknown
- 2007-12-04 EA EA200970537A patent/EA016760B1/ru unknown
- 2007-12-04 BR BRPI0719915-5A2A patent/BRPI0719915A2/pt not_active Application Discontinuation
- 2007-12-05 TW TW096146212A patent/TWI487526B/zh not_active IP Right Cessation
- 2007-12-05 AR ARP070105441A patent/AR064148A1/es unknown
- 2007-12-05 CL CL200703518A patent/CL2007003518A1/es unknown
-
2009
- 2009-06-02 IL IL199082A patent/IL199082A/en active IP Right Grant
- 2009-06-05 ZA ZA200903949A patent/ZA200903949B/xx unknown
- 2009-07-06 NO NO20092541A patent/NO341984B1/no unknown
-
2011
- 2011-01-27 CY CY20111100087T patent/CY1112027T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010511668A5 (enExample) | ||
| JP2010511667A5 (enExample) | ||
| DK2751083T3 (en) | Quinolone compound | |
| HRP20160585T1 (hr) | Antibakterijski derivati kinolina | |
| KR101160183B1 (ko) | 마이코박테리아 저해제로서 사용하기 위한 퀴놀린 유도체 | |
| EP3157521A1 (en) | Substituted indazole compounds as irak4 inhibitors | |
| HRP20100428T1 (hr) | Antibakterijski derivati kvinolina | |
| JP2010511671A5 (enExample) | ||
| WO2013033258A1 (en) | Antibacterial compounds and methods for use | |
| RU2009125520A (ru) | Антибактериальные хинолиновые производные | |
| JP2010511672A5 (enExample) | ||
| CA3081423A1 (en) | Antibacterial compounds | |
| AU2022405116A1 (en) | Raf kinase inhibitors and methods of use thereof | |
| JP2010511670A5 (enExample) | ||
| JP2010511669A5 (enExample) | ||
| RU2009125525A (ru) | Антибактериальные производные хинолина | |
| HRP20110024T1 (hr) | Antibakterijski derivati kvinolina | |
| JP2008543964A5 (enExample) | ||
| US20230357179A1 (en) | Raf kinase inhibitors and methods of use thereof | |
| RU2634122C1 (ru) | Фторхинолоны на основе 4-дезоксипиридоксина | |
| ME01484B (me) | Kinolinski derivati kao antibakterijski agensi | |
| JP2008546825A5 (enExample) | ||
| AU2024311847A9 (en) | Dual raf and tubulin inhibitors and methods of use thereof | |
| AU2024304207A1 (en) | Dual raf and tubulin inhibitors and methods of use thereof | |
| AU2021384582A1 (en) | Novel compound, preparation method thereof, and antibiotic composition comprising same |